1. Home
  2. VRCA
  3. VRCA News

Latest Verrica Pharmaceuticals Inc. (VRCA) News on October 7, 2024

VRCA

MT Newswires

3 days ago

RBC Lowers Price Target on Verrica Pharmaceuticals to $11 From $13, Keeps Outperform, Speculative Risk

VRCA

MT Newswires

5 days ago

Sector Update: Health Care Stocks Softer Wednesday Afternoon

VRCA

MT Newswires

5 days ago

Verrica Pharmaceuticals to Restructure Sales, Operating Teams; Cut Sales Territories

Verrica Pharmaceuticals Announces Restructuring of Commercial Organization
VRCA

GlobeNewswire

5 days ago

Verrica Pharmaceuticals Announces Restructuring of Commercial Organization

Verrica Pharmaceuticals Inc. (VRCA): Worst 52-Week Low Stock to Buy Now
VRCA

Insider Monkey

8 days ago

Verrica Pharmaceuticals Inc. (VRCA): Worst 52-Week Low Stock to Buy Now

Is Verrica Pharmaceuticals Inc. (VRCA) The Worst 52-Week Low Stocks to Buy Now According to Short Sellers?
VRCA

Insider Monkey

12 days ago

Is Verrica Pharmaceuticals Inc. (VRCA) The Worst 52-Week Low Stocks to Buy Now According to Short Sellers?

Verrica Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference in New York
VRCA

GlobeNewswire

a month ago

Verrica Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference in New York

When Will Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Turn A Profit?
VRCA

Simply Wall St.

a month ago

When Will Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Turn A Profit?

VRCA

MT Newswires

2 months ago

RBC Adjusts Price Target on Verrica Pharmaceuticals to $13 From $14, Maintains Outperform

Verrica stock drops after half patients’ tumours gone in skin cancer trial
VRCA

Clinical Trials Arena

2 months ago

Verrica stock drops after half patients’ tumours gone in skin cancer trial

VRCA

MT Newswires

2 months ago

Top Midday Decliners

Why Is Dermatology-Focused Verrica Pharmaceuticals Stock Trading Lower On Wednesday?
VRCA

Benzinga

2 months ago

Why Is Dermatology-Focused Verrica Pharmaceuticals Stock Trading Lower On Wednesday?

VRCA

MT Newswires

2 months ago

Sector Update: Health Care Stocks Edge Higher Premarket Wednesday

Verrica Pharmaceuticals Inc. (VRCA) Reports Q2 Loss, Tops Revenue Estimates
VRCA

Zacks

2 months ago

Verrica Pharmaceuticals Inc. (VRCA) Reports Q2 Loss, Tops Revenue Estimates

VRCA

MT Newswires

2 months ago

Verrica Pharmaceuticals' Shares Surge 26% Pre-Bell on Data From Study of VP-315 to Treat Basal Cell Carcinoma

Verrica Pharmaceuticals Reports Second Quarter 2024 Financial Results
VRCA

GlobeNewswire

2 months ago

Verrica Pharmaceuticals Reports Second Quarter 2024 Financial Results

Verrica Pharmaceuticals Announces Positive Preliminary Topline Results from Part 2 of Phase 2 Clinical Study of VP-315, an Investigational Oncolytic Peptide-Based Immunotherapy for the Treatment of Patients with Basal Cell Carcinoma
VRCA

GlobeNewswire

2 months ago

Verrica Pharmaceuticals Announces Positive Preliminary Topline Results from Part 2 of Phase 2 Clinical Study of VP-315, an Investigational Oncolytic Peptide-Based Immunotherapy for the Treatment of Patients with Basal Cell Carcinoma

Verrica Pharmaceuticals to Report Second Quarter Financial Results and Release Preliminary Topline Results from Part 2 of Phase 2 Trial of VP-315 for the Treatment of Basal Cell Carcinoma on August 14, 2024
VRCA

GlobeNewswire

2 months ago

Verrica Pharmaceuticals to Report Second Quarter Financial Results and Release Preliminary Topline Results from Part 2 of Phase 2 Trial of VP-315 for the Treatment of Basal Cell Carcinoma on August 14, 2024

3 High Insider Ownership US Stocks With Up To 52% Revenue Growth
VRCA

Simply Wall St.

2 months ago

3 High Insider Ownership US Stocks With Up To 52% Revenue Growth

Zevra Therapeutics (ZVRA) Surges 21.9%: Is This an Indication of Further Gains?
VRCA

Zacks

3 months ago

Zevra Therapeutics (ZVRA) Surges 21.9%: Is This an Indication of Further Gains?

VRCA

MT Newswires

3 months ago

Verrica Pharmaceuticals Settles Cantharidin-Related Lawsuit With Dormer Labs

Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
VRCA

GlobeNewswire

3 months ago

Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.

High Insider Ownership Growth Stocks On US Exchange For June 2024
VRCA

Simply Wall St.

3 months ago

High Insider Ownership Growth Stocks On US Exchange For June 2024

Recent 12% pullback would hurt Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) insiders
VRCA

Simply Wall St.

3 months ago

Recent 12% pullback would hurt Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) insiders

Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York
VRCA

GlobeNewswire

4 months ago

Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York

High Insider Ownership Growth Companies On US Exchange May 2024
VRCA

Simply Wall St.

4 months ago

High Insider Ownership Growth Companies On US Exchange May 2024

VRCA

MT Newswires

5 months ago

Verrica Pharmaceuticals Amends Licensing Agreement With Torii Pharmaceutical for Phase 3 Trial of Ycanth

Verrica Pharmaceuticals Announces Amendment to Company’s Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts
VRCA

GlobeNewswire

5 months ago

Verrica Pharmaceuticals Announces Amendment to Company’s Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts

VRCA

MT Newswires

5 months ago

HC Wainwright Adjusts Price Target on Verrica Pharmaceuticals to $14 From $13, Maintains Buy Rating

VRCA

MT Newswires

5 months ago

Needham Adjusts Price Target on Verrica Pharmaceuticals to $16 From $8, Keeps Buy Rating

VRCA

GuruFocus.com

5 months ago

Verrica Pharmaceuticals Inc (VRCA) Q1 2024 Earnings Call Transcript Highlights: Strategic ...

Verrica Pharmaceuticals Inc (VRCA) Reports Q1 2024 Results: A Detailed Financial Review
VRCA

GuruFocus.com

5 months ago

Verrica Pharmaceuticals Inc (VRCA) Reports Q1 2024 Results: A Detailed Financial Review

Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates
VRCA

Zacks

5 months ago

Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates

Verrica Pharmaceuticals Reports First Quarter 2024 Financial Results
VRCA

GlobeNewswire

5 months ago

Verrica Pharmaceuticals Reports First Quarter 2024 Financial Results

Verrica Pharmaceuticals to Present at Upcoming Investor Conferences
VRCA

GlobeNewswire

5 months ago

Verrica Pharmaceuticals to Present at Upcoming Investor Conferences

Verrica Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 13, 2024
VRCA

GlobeNewswire

5 months ago

Verrica Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 13, 2024

Verrica Pharmaceuticals (VRCA) Moves 7.4% Higher: Will This Strength Last?
VRCA

Zacks

5 months ago

Verrica Pharmaceuticals (VRCA) Moves 7.4% Higher: Will This Strength Last?

Strength Seen in Amneal (AMRX): Can Its 12.0% Jump Turn into More Strength?
VRCA

Zacks

5 months ago

Strength Seen in Amneal (AMRX): Can Its 12.0% Jump Turn into More Strength?

Strong week for Verrica Pharmaceuticals (NASDAQ:VRCA) shareholders doesn't alleviate pain of three-year loss
VRCA

Simply Wall St.

6 months ago

Strong week for Verrica Pharmaceuticals (NASDAQ:VRCA) shareholders doesn't alleviate pain of three-year loss

Verrica Pharmaceuticals Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
VRCA

GlobeNewswire

6 months ago

Verrica Pharmaceuticals Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference

Verrica Pharmaceuticals Announces that YCANTH™ Receives New Chemical Entity Status and Orange Book Listing from the FDA
VRCA

GlobeNewswire

6 months ago

Verrica Pharmaceuticals Announces that YCANTH™ Receives New Chemical Entity Status and Orange Book Listing from the FDA

When Will Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Become Profitable?
VRCA

Simply Wall St.

7 months ago

When Will Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Become Profitable?

Verrica Pharmaceuticals Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line
VRCA

Simply Wall St.

7 months ago

Verrica Pharmaceuticals Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Q4 2023 Earnings Call Transcript
VRCA

Insider Monkey

7 months ago

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Q4 2023 Earnings Call Transcript

VRCA

GuruFocus.com

7 months ago

Verrica Pharmaceuticals Inc (VRCA) Reports Fourth Quarter and Full-Year 2023 Financial Results

Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results
VRCA

GlobeNewswire

7 months ago

Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results

Verrica Pharmaceuticals Announces Participation in the TD Cowen 44th Annual Healthcare Conference
VRCA

GlobeNewswire

7 months ago

Verrica Pharmaceuticals Announces Participation in the TD Cowen 44th Annual Healthcare Conference

Verrica Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full-Year 2023 Financial Results on February 29, 2024
VRCA

GlobeNewswire

7 months ago

Verrica Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full-Year 2023 Financial Results on February 29, 2024

Verrica Pharmaceuticals Files Lawsuit Against Canadian Drug Manufacturer for False Advertising and Unfair Competition
VRCA

GlobeNewswire

8 months ago

Verrica Pharmaceuticals Files Lawsuit Against Canadian Drug Manufacturer for False Advertising and Unfair Competition

Verrica Pharmaceuticals Receives Permanent J-Code (J7354) for YCANTH™ from Centers for Medicare and Medicaid Services
VRCA

GlobeNewswire

8 months ago

Verrica Pharmaceuticals Receives Permanent J-Code (J7354) for YCANTH™ from Centers for Medicare and Medicaid Services

HS2 bosses in talks to scrap first-class seats to maintain passenger capacity
VRCA

The Telegraph

8 months ago

HS2 bosses in talks to scrap first-class seats to maintain passenger capacity

Bridgewater Bancshares, Inc. (NASDAQ:BWB) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year
VRCA

Simply Wall St.

8 months ago

Bridgewater Bancshares, Inc. (NASDAQ:BWB) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year

EPIX: Updated Data for Phase 1 Trial of Masofaniten Shows 63% of Patients Achieved PSA <0.2 ng/mL…
VRCA

Zacks Small Cap Research

8 months ago

EPIX: Updated Data for Phase 1 Trial of Masofaniten Shows 63% of Patients Achieved PSA <0.2 ng/mL…

LexinFintech Holdings Ltd.'s (NASDAQ:LX) most bullish insider is CEO Wenjie Xiao, and their holdings value went up by 14% last week
VRCA

Simply Wall St.

8 months ago

LexinFintech Holdings Ltd.'s (NASDAQ:LX) most bullish insider is CEO Wenjie Xiao, and their holdings value went up by 14% last week

Obsidian Energy Announces 2024 Guidance With 12 Percent Growth in Average Annual Production to 36,000 boe/d
VRCA

Newsfile

8 months ago

Obsidian Energy Announces 2024 Guidance With 12 Percent Growth in Average Annual Production to 36,000 boe/d

VRCA

Associated Press Finance

8 months ago

Northfield: Q4 Earnings Snapshot

Northfield Bancorp, Inc. Announces the Appointment of Dr. Rachana A. Kulkarni to Its Board of Directors
VRCA

GlobeNewswire

8 months ago

Northfield Bancorp, Inc. Announces the Appointment of Dr. Rachana A. Kulkarni to Its Board of Directors

TotalEnergies (TTE) Eyes March Restart for Denmark's Tyra Field
VRCA

Zacks

8 months ago

TotalEnergies (TTE) Eyes March Restart for Denmark's Tyra Field

7 Potential Short-Squeeze Stocks Poised for Rapid Gains
VRCA

InvestorPlace

8 months ago

7 Potential Short-Squeeze Stocks Poised for Rapid Gains

3 Promising Blockchain Stocks to Buy to Become a Crypto Millionaire
VRCA

InvestorPlace

8 months ago

3 Promising Blockchain Stocks to Buy to Become a Crypto Millionaire

GrafTech Announces Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast
VRCA

Business Wire

9 months ago

GrafTech Announces Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast

VRCA

Business Wire

9 months ago

Western Asset High Income Fund II Inc. Authorizes Rights Offering

Natural Grocers by Vitamin Cottage (NYSE:NGVC) Has Some Way To Go To Become A Multi-Bagger
VRCA

Simply Wall St.

9 months ago

Natural Grocers by Vitamin Cottage (NYSE:NGVC) Has Some Way To Go To Become A Multi-Bagger

VRCA

Business Wire

9 months ago

Putnam Investments Announces 19(a) Notices for Closed-End Municipal Funds

Tejon Ranch Company to Start Construction on Its First Residential Multi-Family Community, Terra Vista at Tejon
VRCA

GlobeNewswire

9 months ago

Tejon Ranch Company to Start Construction on Its First Residential Multi-Family Community, Terra Vista at Tejon

i-80 Provides 2023 Summary & 2024 Plans - Highlighting Numerous Achievements & Catalysts
VRCA

PR Newswire

9 months ago

i-80 Provides 2023 Summary & 2024 Plans - Highlighting Numerous Achievements & Catalysts

New Mountain Finance Corporation Schedules its Fourth Quarter and Year Ended December 31, 2023 Earnings Release and Conference Call
VRCA

Business Wire

9 months ago

New Mountain Finance Corporation Schedules its Fourth Quarter and Year Ended December 31, 2023 Earnings Release and Conference Call

Verrica Pharmaceuticals Announces Last Patient Dosed in Part 2 of Phase 2 Study of VP-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy, for the Treatment of Basal Cell Carcinoma
VRCA

GlobeNewswire

9 months ago

Verrica Pharmaceuticals Announces Last Patient Dosed in Part 2 of Phase 2 Study of VP-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy, for the Treatment of Basal Cell Carcinoma

REX (REX) is on the Move, Here's Why the Trend Could be Sustainable
VRCA

Zacks

9 months ago

REX (REX) is on the Move, Here's Why the Trend Could be Sustainable

Verrica Pharmaceuticals Announces Receipt of Minutes from Type C Meeting with FDA Regarding Clinical Development of YCANTH™ for the Treatment of Common Warts
VRCA

GlobeNewswire

9 months ago

Verrica Pharmaceuticals Announces Receipt of Minutes from Type C Meeting with FDA Regarding Clinical Development of YCANTH™ for the Treatment of Common Warts

Verrica Pharmaceuticals Announces Specialty Pharmacy Partnership Agreement with Walgreens to Distribute YCANTH™
VRCA

GlobeNewswire

9 months ago

Verrica Pharmaceuticals Announces Specialty Pharmacy Partnership Agreement with Walgreens to Distribute YCANTH™

Despite recent sales, Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) insiders remain the largest stockholders with 39% ownership
VRCA

Simply Wall St.

9 months ago

Despite recent sales, Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) insiders remain the largest stockholders with 39% ownership

AudioCodes Ltd.'s (NASDAQ:AUDC) Stock Is Going Strong: Have Financials A Role To Play?
VRCA

Simply Wall St.

9 months ago

AudioCodes Ltd.'s (NASDAQ:AUDC) Stock Is Going Strong: Have Financials A Role To Play?

Investor Optimism Abounds Compass Minerals International, Inc. (NYSE:CMP) But Growth Is Lacking
VRCA

Simply Wall St.

10 months ago

Investor Optimism Abounds Compass Minerals International, Inc. (NYSE:CMP) But Growth Is Lacking

Verrica Pharmaceuticals’ Development and Commercialization Partner, Torii Pharmaceutical Co., Ltd., Announces Positive Top-line Results from a Confirmatory Phase 3 Trial of TO-208 for the Treatment of Molluscum Contagiosum in Japan
VRCA

GlobeNewswire

10 months ago

Verrica Pharmaceuticals’ Development and Commercialization Partner, Torii Pharmaceutical Co., Ltd., Announces Positive Top-line Results from a Confirmatory Phase 3 Trial of TO-208 for the Treatment of Molluscum Contagiosum in Japan

i-80 Gold Releases High-Grade Results from Underground Drilling at Granite Creek
VRCA

PR Newswire

10 months ago

i-80 Gold Releases High-Grade Results from Underground Drilling at Granite Creek

Is 8.8% Yielding Redwood Trust a No-Brainer Buy or a Stock to Avoid?
VRCA

Motley Fool

10 months ago

Is 8.8% Yielding Redwood Trust a No-Brainer Buy or a Stock to Avoid?

Altus Power Kicks Off December Investor Engagement
VRCA

Business Wire

10 months ago

Altus Power Kicks Off December Investor Engagement

VRCA

Business Wire

a year ago

Legg Mason Partners Fund Advisor, LLC Announces Distributions for the Months of December 2023, January and February 2024

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Q3 2023 Earnings Call Transcript
VRCA

Insider Monkey

a year ago

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Q3 2023 Earnings Call Transcript

Organogenesis Holdings Inc. (NASDAQ:ORGO) Q3 2023 Earnings Call Transcript
VRCA

Insider Monkey

a year ago

Organogenesis Holdings Inc. (NASDAQ:ORGO) Q3 2023 Earnings Call Transcript

VRCA

Thomson Reuters StreetEvents

a year ago

Q3 2023 BlackRock Capital Investment Corp Earnings Call

Savara Reports Third Quarter Financial Results and Provides Business Update
VRCA

Business Wire

a year ago

Savara Reports Third Quarter Financial Results and Provides Business Update

VRCA

GuruFocus.com

a year ago

BlackRock Capital Investment Corp (BKCC) Reports Solid Earnings Growth and NAV Increase for Q3 2023

VRCA

Associated Press Finance

a year ago

BlackRock Kelso: Q3 Earnings Snapshot

BlackRock Capital Investment Corporation Reports Financial Results for the Quarter Ended September 30, 2023, Declares Quarterly Cash Dividend of $0.10 per Share
VRCA

Business Wire

a year ago

BlackRock Capital Investment Corporation Reports Financial Results for the Quarter Ended September 30, 2023, Declares Quarterly Cash Dividend of $0.10 per Share

VRCA

Business Wire

a year ago

JBG SMITH Announces Third Quarter 2023 Results

ACELYRIN, INC. Reports Third Quarter 2023 Financial Results and Recent Highlights
VRCA

GlobeNewswire

a year ago

ACELYRIN, INC. Reports Third Quarter 2023 Financial Results and Recent Highlights

VRCA

Thomson Reuters StreetEvents

a year ago

Q1 2024 1-800-Flowers.Com Inc Earnings Call

1-800-Flowers.com Inc (FLWS) Reports Q1 2024 Earnings: Net Loss of $31.2 Million
VRCA

GuruFocus.com

a year ago

1-800-Flowers.com Inc (FLWS) Reports Q1 2024 Earnings: Net Loss of $31.2 Million

John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) Q1 2024 Earnings Call Transcript
VRCA

Insider Monkey

a year ago

John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) Q1 2024 Earnings Call Transcript

Share on Social Networks: